Taiwan FDA registration 4817eee127a3fbe1ff9260c69bed2a31
"Borrhen" HER2/Chr17cen fluorescence in situ hybridization probe (unsterilized)
TW: “博錸”HER2/Chr17cen螢光原位雜交探針 (未滅菌)
Taiwan·Risk Class 1·PLEXBIO CO., LTD.·Registered Jan 23, 2015 – Jan 23, 2020CancelledRegistration details
- Analysis ID
- 4817eee127a3fbe1ff9260c69bed2a31
Company information
- Manufacturer
- PLEXBIO CO., LTD.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- PLEXBIO CO., LTD.
Product details
- Intended Use
- Limited to the first level identification range of immunopathological histochemical reagents and kits (B.1860) of the Measures for the Administration of Medical Devices.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.1860 Immunopathological histochemistry reagents and kits
- Import Information
- Domestic
Dates and status
- Registration Date
- Jan 23, 2015
- Expiry Date
- Jan 23, 2020
- Cancellation Date
- Dec 05, 2017
Cancellation information
- Status
- Logged out
- Reason
- 自請註銷
About this record
Access comprehensive regulatory information for "Borrhen" HER2/Chr17cen fluorescence in situ hybridization probe (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 4817eee127a3fbe1ff9260c69bed2a31 and manufactured by PLEXBIO CO., LTD.. The authorized representative in Taiwan is PLEXBIO CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices